The clinical pharmacologist in drug regulation: A European perspective

被引:1
作者
Rawlins, MD
机构
关键词
drug regulation; clinical pharmacology;
D O I
10.1046/j.1365-2125.1996.03779.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The clinical pharmacologist in drug regulation has many roles to play. These include responsibilities for the premarketing assessment of a new product's efficacy and safety, for scrutiny of the summary of Product Characteristics, and for monitoring its performance after marketing. Furthermore, the clinical pharmacologist has a subsidiary responsibility in examining the results of preclinical pharmacological and toxicological studies. 2 Clinical pharmacologists in regulatory authorities have one further, and crucial, responsibility-humility. From their training and experience they will (or should) know of their own scientific limitations and of the necessity for seeking help and advice from other disciplines.
引用
收藏
页码:59 / 61
页数:3
相关论文
共 50 条
  • [41] What influences antibiotic sales in rural Bangladesh? A drug dispensers' perspective
    Matin, Mohammad Abdul
    Khan, Wasif Ali
    Karim, Mohammad Mahbubul
    Ahmed, Sabeena
    John-Langba, Johannes
    Sankoh, Osman A.
    Gyapong, Margaret
    Kinsman, John
    Wertheim, Heiman
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2020, 13 (01)
  • [42] What influences antibiotic sales in rural Bangladesh? A drug dispensers’ perspective
    Mohammad Abdul Matin
    Wasif Ali Khan
    Mohammad Mahbubul Karim
    Sabeena Ahmed
    Johannes John-Langba
    Osman A. Sankoh
    Margaret Gyapong
    John Kinsman
    Heiman Wertheim
    [J]. Journal of Pharmaceutical Policy and Practice, 13
  • [43] Total Intravenous Anesthesia Versus Inhalation Anesthesia: A Drug Delivery Perspective
    Egan, Talmage D.
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2015, 29 : S3 - S6
  • [44] A brief review of Phase 1 and Clinical Pharmacology statistics in clinical drug development
    Patterson, Scott D.
    Jones, Byron
    [J]. PHARMACEUTICAL STATISTICS, 2007, 6 (02) : 79 - 87
  • [45] Drug related adverse event assessment in neonates in clinical trials and clinical care
    Yalcin, Nadir
    van den Anker, John
    Samiee-Zafarghandy, Samira
    Allegaert, Karel
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (09) : 803 - 816
  • [46] Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology
    Stephanie N. Liu
    Chunze Li
    [J]. Cancer Chemotherapy and Pharmacology, 2021, 87 : 743 - 765
  • [47] European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology
    Andrej Belančić
    Carla Sans-Pola
    Emilie Jouanjus
    Pau Alcubilla
    Ana Lucía Arellano
    Miodrag Žunić
    Rita Nogueiras-Álvarez
    Rossana Roncato
    Joaquín Sáez-Peñataro
    [J]. European Journal of Clinical Pharmacology, 2022, 78 : 691 - 694
  • [48] European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology
    Belancic, Andrej
    Sans-Pola, Carla
    Jouanjus, Emilie
    Alcubilla, Pau
    Lucia Arellano, Ana
    Zunic, Miodrag
    Nogueiras-Alvarez, Rita
    Roncato, Rossana
    Saez-Penataro, Joaquin
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (04) : 691 - 694
  • [49] Less Is More: Norwegian Drug Regulation, Antibiotic Policy, and the "Need Clause"
    Hobaek, Bard
    Lie, Anne Kveim
    [J]. MILBANK QUARTERLY, 2019, 97 (03) : 762 - 795
  • [50] Advancing structured decision-making in drug regulation at the FDA and EMA
    Angelis, Aris
    Phillips, Lawrence D.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (02) : 395 - 405